Thalassemia is a category of inherited blood disorders, becoming a primary health threat due to its increased prevalence worldwide. Through examination and testing of Thalassemia is widely accessible ...

Fulgent Genetics, Inc. made 49 cents a share (non-GAAP) on 283.5 million of revenues in FY2024 (up 7% over FY2023 sales). On a GAAP basis, Fulgent had a loss of $1.49 a share.